The latter patient carried a C3 gain-of-function mutation and had lost two previous kidney transplants owing to HUS recurrences; he was successfully treated with eculizumab for influenza-triggered HUS [33]. This evidence concerns the gene C3 and hemolytic-uremic syndrome.